Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

RTEL1 influences the abundance and localization of TERRA RNA

Subjects

Abstract

Telomere repeat containing RNAs (TERRAs) are a family of long non-coding RNAs transcribed from the subtelomeric regions of eukaryotic chromosomes. TERRA transcripts can form R-loops at chromosome ends; however the importance of these structures or the regulation of TERRA expression and retention in telomeric R-loops remain unclear. Here, we show that the RTEL1 (Regulator of Telomere Length 1) helicase influences the abundance and localization of TERRA in human cells. Depletion of RTEL1 leads to increased levels of TERRA RNA while reducing TERRA-containing R loops at telomeres. In vitro, RTEL1 shows a strong preference for binding G-quadruplex structures which form in TERRA. This binding is mediated by the C-terminal region of RTEL1, and is independent of the RTEL1 helicase domain. RTEL1 binding to TERRA appears to be essential for cell viability, underscoring the importance of this function. Degradation of TERRA-containing R-loops by overexpression of RNAse H1 partially recapitulates the increased TERRA levels and telomeric instability associated with RTEL1 deficiency. Collectively, these data suggest that regulation of TERRA is a key function of the RTEL1 helicase, and that loss of that function may contribute to the disease phenotypes of patients with RTEL1 mutations.

Introduction

RTEL1 is an (Fe-S) cluster containing helicase that belongs to the DEAH superfamily 2 (SF2) and specifies 5’-3’ helicase activity1,2. The RTEL1 gene was first identified in a four-gene cluster on chromosome 20 found to be amplified in gastrointestinal cancers (then called NHL)3. The gene was subsequently identified as a regulator of telomere length in the mouse and renamed RTEL1 (for Regulator of Telomere Length)4.

RTEL1 plays diverse functional roles that bear upon several aspects of genome integrity and gene expression. RTEL1 influences telomere stability by facilitating replication at telomeres, possibly by removing secondary structures that would otherwise inhibit replication fork progression5,6. In addition, it influences genome stability via its roles in regulating DNA replication and DNA recombination in mammals, C. elegans, and in plants7,8. More recently, RTEL1 has been shown to promote MiDAS, a mitotic DNA synthesis process that occurs in common fragile sites and other late replicating genomic loci9,10. Finally, the protein also appears to influence RNA trafficking, as cells from patients with inherited RTEL1 mutations exhibit aberrant localization of pre-U2 RNA and associated ribonucleoproteins (RNPs)11.

Germline mutations in RTEL1 underlie Dyskeratosis Congenita (DC) and the more severe variant, Hoyeraal-Hreidarsson syndrome (HH)12,13. At the cellular level, these diseases are associated with very short and heterogeneous telomeres, genomic instability, and sensitivity to clastogens, consistent with the role of RTEL1 in preserving genome integrity14,15. Some disease-causing RTEL1 alleles exhibit autosomal dominant behavior, suggesting that the protein may function in a dimeric or multimeric assembly16,17,18,19.

Telomeric repeat containing RNAs (TERRAs) are RNA polymerase II transcripts emanating from subtelomeric regions that extend into the TTAGGG telomeric repeats20,21,22,23. TERRA transcripts are heterogeneous in size and can be associated with chromosome ends by forming R-loops either co-transcriptionally or post-transcriptionally. In the latter circumstance, the TERRA RNA may be recruited via binding to telomeric proteins20,22,24,25,26,27,28,29.

TERRA is transcribed from at least a subset of chromosome ends, and the mechanisms of regulation may differ between chromosomes. TERRA binds to telomeres as well as interstitial sites where it can influence gene expression22,24,30,31. Despite this broad distribution of binding sites, the most prominent role of TERRA is at the telomere. Depletion of TERRA leads to myriad indices of telomere dysfunction such as the loss of telomeric DNA, the formation of telomere damage-associated foci (TIFs)32, and telomere driven chromosome aberrations. Notably, TERRA interacts with, and appears to antagonize the functions of the chromatin remodeler ATRX, which plays a key role in modulating telomeric chromatin structure24,33,34.

Owing to its G-rich sequence, TERRA can form stable, four-stranded structures known as G-quadruplexes in vitro35,36,37. G-quadruplex structures can form in both G-rich DNA and RNA sequences in vitro under physiological conditions, and would constitute barriers to protein translocation during DNA replication, transcription, and mRNA translation if present in cells38. There are dedicated protein machineries with the capacity to unfold G-quadruplex structures in mammalian cells39. However, it is not clear whether TERRA forms G-quadruplex structures in vivo and if so, whether those structures are biologically relevant.

Here, we present evidence that RTEL1 influences the levels and localization of TERRA via direct physical interaction. We identified an RNA-binding domain in the RTEL1 C-terminus that exhibits a strong preference for G-quadruplex folded TERRA RNA over unfolded RNA. RTEL1 deficiency causes a dramatic increase in TERRA levels, but reduced localization of TERRA RNA to chromosome ends. Our data thus reveal a previously unrecognized function of RTEL1 in regulating the disposition of the TERRA RNA. The data are consistent with the observation that misregulation of TERRA compromises telomere maintenance, and suggest an additional mechanism by which RTEL1 hypomorphism may cause telomere instability and contribute to the clinical phenotypes of DC and HH24,25,30,40,41,42,43,44,45,46.

Results

Homozygosity of the RTEL1R1264H pathogenic variant causes HH, which occurs as a heterozygous founder mutation in the Ashkenazi Jewish population15. The mutation falls within the RING domain at the protein’s C-terminus, and its implication as an underlying cause of HH provided the first evidence of the RING domain’s functional significance15. Typically, the RING domain structure is dependent upon the coordination of Zn2+ atoms via cysteine and histidine residues. The R→H change in the RTEL1R1264H RING domain introduces an additional potential Zn2+ coordination partner that may alter the RING domain’s structure.

Domain analysis of RTEL1

To examine the functional consequences of the RTEL1R1264H mutation at the molecular level, we designed a series of constructs for the production of various RTEL1 protein domains (Fig. 1a). First, differentially tagged (myc and FLAG) wild type and RTEL1R1264H full-length complementary DNAs (cDNAs) were co-expressed in HEK293 cells. FLAG-tagged RTEL1 was recovered in myc immunoprecipitates of both RTEL1R1264H and wild type RTEL1, suggesting that the protein can form a higher order assembly (Fig. 1b, left).

Fig. 1: Domain Analysis of RTEL1.
figure1

a Schematic representation of RTEL1 proteins and constructs used in this study. The location of the RTEL1R1264H mutation is indicated with a green star and G4 binding is illustrated. b RTEL1 interacts with itself in cells and the RTEL1R1264H mutation disrupts interactions within the RING domain. Left, Myc immunoprecipitations from HEK293T cells co-expressing FLAG and myc-tagged RTEL1 (FL) and RTEL1R1264H (FL RH) were carried out. Immunoblotting with FLAG indicates co-IP of both RTEL1 and RTEL1R1264H. Center, immunoblotting with myc indicates co-IP of RTEL1∆1097 (∆1097), but not RTEL1∆1097 R1264H (∆1097 RH) with GFP-tagged RTEL1 and RTEL1R1264H. Right, immunoblotting with FLAG shows co-IP of RTEL1∆1097, but not RTEL1∆1097R1264H. Molecular weight markers, KDa are shown. All immunoblotting experiments were repeated at least three times with similar results. c Oligomeric states of RTEL1 proteins were determined by SEC-MALS analysis of RTEL1∆762 (blue), RTEL1∆762R1264H (red), and RTEL1∆762-1097 (green) at 150 and 300 mM NaCl. Normalized A280 are shown and the calculated molecular mass is shown as a line in the corresponding color across each peak with the secondary scale on the right. The expected and calculated molecular weights are shown (see also Supplementary Fig. 1).

This assembly is mediated by spatially distinct regions of RTEL1, one in the N-terminal helicase domain and the other in the C-terminal RING domain. The protein product of FLAG-RTEL1∆1097, which comprises the C-terminal 203 amino acids of RTEL1 including the PIP box and RING domain (Fig. 1a), co-immunoprecipitated with both full-length RTEL1 and itself. These interactions were abolished by the RTEL1R1264H mutation (Fig. 1b, center and right), indicating that the RING domain constitutes an independent homotypic interaction domain that is rendered non-functional by the RTEL1R1264H mutation. Full-length RTEL1R1264H retains the ability to interact with wild type full-length RTEL1, indicating that the N-terminal half of RTEL1 also promotes oligomerization (Fig. 1b, left).

To characterize the C-terminal oligomerization domain of RTEL1, we began with RTEL1∆762 (which lacks the helicase domain but retains the harmonin N- like, PIP box, and RING domains of RTEL1), and designed variants, including the RTEL1∆762R1264H mutation and various deletions within RTEL1∆762 that removed the RING domain and additional proximal sequences (Fig. 1a). We purified recombinant His-tagged RTEL1∆762 from E.coli. Size exclusion chromatography (SEC) revealed that RTEL1∆762 was present in two monodispersed peaks (Fig. 1c). Coupling the SEC with multiple angle light scattering (SEC-MALS) showed the molecular masses of the RTEL1∆762 peaks to be 65.3 ± 0.5% and 126 ± 0.2% kDa, respectively, corresponding to the expected monomer and dimer masses of RTEL1∆762 (62 kDa and 124 kDa) (Fig. 1c). The dimer peak was virtually absent in the RTEL1∆762R1264H protein and the calculated molecular mass was 65.7 ± 0.2% kDa, corresponding to that of a monomer (Fig. 1c). The RTEL1∆762-1097 protein, which lacks the RING domain, is also a monomer (Fig. 1c).

SEC-MALS experiments showed that the RTEL1∆762 dimeric species was favored at higher ionic strength. Elevation of the salt concentration from 150 mM to 300 mM NaCl favored the RTEL1∆762 dimeric species but had no effect on the oligomeric state of either RTEL1∆762R1264H or RTEL1∆762-1097 proteins (Fig. 1c). These results suggest that dimerization of the C-terminal RTEL1 domain is dependent on the RING domain in combination with hydrophobic interactions that are stabilized at higher ionic strength. Hence, the RING domain of RTEL1 is a dimerization domain and the RTEL1R1264H mutation disrupts that function in vitro and in cells.

Heterotypic interactions at the RTEL1 C-terminus

Having identified the homotypic interaction in the C-terminus of RTEL1, we reasoned that heterotypic protein interactions at the RTEL1 C-terminus could also provide insight regarding helicase independent functions of RTEL1, and shed light on the function(s) of the RING domain, as well as the consequences of the RTEL1R1264H mutation. We used a BioID proximity dependent labeling system47 to identify RTEL1 C-terminal interacting proteins. This system uses the promiscuous biotin ligase BirAR118G fused to the protein of interest. Upon addition of biotin to cells expressing BirA fusion proteins, biotin is covalently linked via lysine residues within a 10 nm radius of the BirAR118G tag48, and biotinylated proteins can subsequently be purified via streptavidin binding. The biotin-labeled proteins can then be identified by mass spectrometry47.

BirAR118G was fused to the C-terminus of full-length RTEL1 and RTEL11-1097, from which part of the second Harmonin N-like repeat, the PIP box, and the RING domain are deleted (see Fig. 1a and Supplementary Fig. 1A). RTEL1 is normally located in the nucleus and fusion to BirA did not change its intracellular localization (Supplementary Fig. 1B). Nevertheless, the biotin-labeled proteins identified in this experiment included numerous RNA-binding proteins that function in the cytoplasm. These RNA-binding proteins were enriched by interaction with full-length RTEL1 relative to RTEL11–1097. Eighteen proteins obtained in our screen were also recovered in a screen to identify proteins bound to the telomeric RNA, TERRA28 (Supplementary Fig. 1C). Additionally, SFPQ and NONO have been recently characterized as TERRA-binding proteins and were among the top hits in our screen49. RTEL1 was also found in a separate screen for TERRA interacting proteins24.

The RTEL1 C-terminal domain preferentially binds TERRA RNA

We did not observe direct interactions between RTEL1 and the TERRA-binding proteins previously identified. Instead, we found that RTEL1 bound TERRA directly in vitro via a domain in the C-terminus. We assayed binding of RTEL1∆762 (Fig. 1a) to TERRA by fluorescence anisotropy. First, we determined the dissociation constant (KD) for fluorescein labeled G-quadruplex containing TERRA RNA (TERRA), a mutant TERRA RNA that is unable to form the G-quadruplex structure (TERRA-MUT), and TERRA RNA not folded into a G-quadruplex (Fig. 2a)36. TERRA RNA and the analogous DNA molecules were heated to 95 °C then slowly cooling them in 50 mM KCl. The presence of G-quadraplex structures in these substrates was validated by gel shift and circular dichroism as previously described36,50. Two RNAs unrelated to TERRA that were either unstructured (AU-rich) or differently structured (PolyA) were also examined51 (Fig. 2b). Fifty nanomolar RNA was incubated with increasing concentrations of RTEL1∆762 (0–5 µM) and incubated for 30 min at room temperature. RTEL1∆762 bound to all tested RNAs and showed a striking preference for the folded TERRA RNA, exhibiting a 500-fold preference over the PolyA RNA, and 100-fold over the TERRA-MUT substrate incapable of forming G-quadruplexes (Fig. 2b and Supplementary Fig. 2A).

Fig. 2: The RTEL1 C-terminal Domain Binds TERRA and other G-quadruplex Structures.
figure2

a Sequences of DNA and RNA substrates used in this study. b Nucleic acid binding of RTEL1 proteins lacking the helicase domains was monitored by fluorescence anisotropy. Bar graph shows dissociation constants (KD) for TERRA and TERRA-MUT RNAs folded in the presence and absence of KCl and, AU-rich, and polyA RNA controls. c Increasing concentrations of the indicated oligonucleotides were added to reactions containing RTEL1 proteins and a 24mer FAM-TERRA-MUT RNA at 200 nM. Bar graphs depict apparent dissociation constants (Ki) derived by competition of the bound FAM-TERRA-MUT by the indicated oligonucleotides using fluorescence anisotropy. d Ki’s of the indicated RTEL1 deletion constructs were derived by competition studies of FAM-TERRA-MUT and indicated RTEL1 proteins at 1 µM as in panel C. No binding signal was observed for the RTEL1∆1143 protein. All binding assays were conducted in triplicate, mean and standard deviation are shown. e RNA IP assays were done in HEK293T cells transfected with FLAG-tagged RTEL1, ∆762, TRF1 or vector only control. Precipitated nucleic acids were treated with DNAse I for 1 h at 37 °C. IP RNA was analyzed by slot blotting and detected by autoradiography using a telomeric probe. Quantitation of four independent experiments with the mean and standard deviation of relative RNA-IP normalized to the vector only control is shown. Five percent of the input is shown in the top two rows. RNAse treatment is indicated (see also Supplementary Figs. 27).

The KD for RTEL1∆762 binding to TERRA (<10 nM) is at the detection limit for anisotropy, which may compromise the accuracy of the measurement. As an alternative to direct determination of KD, we again used fluorescence anisotropy to measure the ability of substrates to compete with TERRA-MUT RNA and thereby derive Ki values as a surrogate for the apparent KD. RTEL1∆762, RTEL1∆762R1264H, and RTEL1∆762-1097 proteins (Fig. 1a) were pre-incubated with TERRA-MUT RNA (Fig. 2a) for 30 min to allow protein–RNA complexes to form, followed by addition of increasing amounts of wild type TERRA RNA or DNA competitor substrates. The Ki of RTEL1∆762 for the folded TERRA RNA was 17 ± 3 nM, 26-fold greater affinity than binding to TERRA-MUT RNA (Ki 442 ± 0.74) (Fig. 2c and Supplementary Fig. 2B).

RTEL1 bound G strand telomeric DNA (hTelo) with similar affinity to TERRA RNA; however, the preference for folded telomeric DNA relative to unfolded DNA (hTelo-MUT) is diminished by approximately threefold. The Ki for RTEL1∆762 binding hTelo DNA was 29 ± 4 nM, and for hTelo-MUT DNA (Ki 93 ± 11 nM) (Fig. 2c and Supplementary Fig. 2B). Hence, this domain of RTEL1 discriminates G4 from other RNA structures to greater extent than the same structures in DNA. Within the context of telomeric chromatin, it is unclear whether G4 DNA and RNA structures co-exist, but the selectivity of RTEL1 for folded RNA may be relevant to its telomeric functions.

The G4-binding domain of RTEL1

To identify the location of the G4-binding domain in the RTEL1 C-terminus, we used fluorescence anisotropy as above with fragments of RTEL1∆762 (Fig. 1a). The RTEL1∆762R1264H protein displayed similar binding affinities to the wild type RTEL1∆762 protein with only a two- to fourfold difference in Ki values (Fig. 2c and Supplementary Fig. 3). These data indicate that RNA/DNA binding is not directly mediated by the RING domain. The decreased apparent affinity of RTEL1∆762R1264H likely reflects the difference in valency of the TERRA-binding domain in monomeric vs. dimeric RTEL1∆762.

Deletion of the C-terminal 230 residues of ∆762 (resulting in RTEL1∆762-1097 protein) reduced binding affinities by approximately 15-fold (Fig. 2c and Supplementary Fig. 2B) and led to a reduced preference for TERRA—6.7-fold relative to the 26.4-fold preference for TERRA in the wild type protein. Unlike binding to RTEL1∆762, the residual binding activity of RTEL1∆762-1097 was acutely sensitive to salt concentration (Supplementary Fig. 4). The binding affinity and selectivity for G4 binding of the RTEL1∆1118 protein product was similar to RTEL1∆762 (Fig. 2d), whereas binding was largely absent for RTEL1∆1143 (Fig. 2d and Supplementary Figs. 3 and  5). These data suggest that G4 binding is primarily specified by residues between amino acid 1097 and the RING domain (Fig. 1a).

As RTEL1 functions affect interstitial as well as telomeric chromosomal sites, we asked whether RTEL1 bound to G4 structures forming in RNA encoded from interstitial loci. We used two RNAs predicted to form G4 structures that fall within the 5’ untranslated regions of NRAS and BCL2 (Fig. 2a)36. RTEL1∆762, RTEL1∆762R1264H, and RTEL1∆762-1097 proteins bound both NRAS and BCL2 RNAs with similar affinities to TERRA (Supplementary Fig. 6a, b).

RTEL1 binds RNA in cells

To determine whether RTEL1 bound RNA in cells, we performed 4-thiouridine (4SU) photoactivatable ribonucleoside-enhanced crosslinking and immunoprecipitation (PAR-CLIP)52. FLAG immunoprecipitation from HEK293 cells overexpressing FLAG-HA-tagged RTEL1 and RTEL1∆762 was performed followed by RNAse treatment. RNA within immunoprecipitated complexes was 5’ end-radiolabeled with polynucleotide kinase and visualized by autoradiography. Both full-length RTEL1 and RTEL1∆762 immunoprecipitates contained radiolabeled RNA (Supplementary Fig. 6d, e). We were unable to obtain reliable RNA sequencing data from the material in the RTEL1 PAR-CLIP, possibly due to the structure of the RNA(s) bound in that context.

To determine if the cellular RNAs bound by RTEL1 included TERRA, we performed RNA-immunoprecipitations (RNA-IP) of overexpressed FLAG-RTEL1, FLAG-RTEL1∆762, and FLAG-TRF1 (as a positive control for a TERRA-binding protein29,53). The precipitated nucleic acids were treated in vitro with DNAseI, and RNAseA (where indicated). The signal was abolished upon pre treatment with RNAseA but resistant to DNAseI treatment confirming the specificity for RNA in this assay. The pretreated nucleic acids were slot blotted, probed for telomere repeats and other RNAs then visualized by autoradiography (Fig. 2e and Supplementary Fig. 7B). Expression levels of the immunoprecipitated proteins are shown in (Supplementary Fig. 7A). Consistent with our biochemical studies we found that RTEL1 and RTEL1∆762 bind TERRA, indicating that at least in part, the RNAs identified in PAR-CLIP experiments include TERRA (Fig. 2; Supplementary Figs. 6D, E and  7A, B). Also consistent with our in vitro studies, RTEL1 immunoprecipitations recovered MYC RNA (which has a G- quadruplex forming sequence its promoter region54) and other RNAs (Supplementary Figs. 6D, E and  7B).

RTEL1 influences TERRA levels

To understand the functional significance of RTEL1 binding to TERRA, we assessed the disposition of TERRA in the context of RTEL1 deficiency. RTEL1 was inactivated via CRISPR-Cas9-mediated deletion of exon #2 in HEK293 cells (hereafter, RTEL1-KO)55 (Fig. 3a, b). The effect of RTEL1 deficiency on telomere stability was examined by fluorescence in situ hybridization (FISH) using a PNA-[TTAACCC]3 probe (Tel FISH). RTEL1-KO cells displayed a significant loss of telomere signal from one or both sister chromatids when compared to wild type HEK293 cells (48.9% ± 11.6 vs. 19.4% ± 6.2) (Fig. 3c), consistent with previous results in both human and mouse cells1,6,15,56,57. Similar results were obtained using a PNA-[TTAAGGG]3 probe (Supplementary Fig. 7C), indicating that the loss occurred on both strands of telomeric DNA.

Fig. 3: RTEL1 Influences TERRA Levels.
figure3

a Sequence alignment of the PCR products amplified from the HEK293 cells genomic segment of RTEL1 targeted by sgRNA revealing disruption of the coding sequence (exon #2 of RTEL1). b Western blot of RTEL1 protein levels in wild type and RTEL1 knockout HEK293 cells. Molecular weight markers, KDa are shown. Immunoblotting experiments were repeated at least three times producing similar results. c Quantification of telomere loss per chromatid. Data represents the average of at least 50 metaphases as mean and standard deviation (***p < 0.001, two-sided t-test). d TERRA levels at specific chromosome ends are elevated in RTEL1 deficient cells. Bars represent the relative TERRA expression measured by qRT-PCR at 18 chromosome ends. Values are sample averages of at least four experimental repeats (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, two-sided t-test). e TERRA levels are elevated in cells from a panel of patient derived LCL lines. TERRA levels were measured by qRT-PCR. Values are sample averages of at least three experimental repeats and p-values are listed in Supplementary Fig. 9E (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, two-sided t-test). f TERRA levels are elevated in a fibroblast cell line derived from a HHS patient homozygous for the RTEL1R1264H allele. TERRA levels were measured by qRT-PCR. Values are sample averages of at least three experimental repeats (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, two-sided t-test) (see also Supplementary Fig. 9). For qRT-PCR means and standard deviations are shown.

We next examined the levels of TERRA RNA. TERRA transcription initiates at subtelomeric regions and extends into the telomeric repeats. The levels of TERRA transcripts originating at various chromosome ends was measured by quantitative reverse transcription PCR (qRT-PCR) using primers derived from the respective subtelomeric sequences31,46,58 (Supplementary Table 1). We tested 18 chromosome ends, some with more than one primer set. We found that TERRA levels were markedly elevated in RTEL1-KO cells when compared to wild type cells. The fold change was highest for chromosome ends 2q, 10q, 13q, and 21q (Fig. 3d). These results are consistent with the view that TERRA transcription is controlled by different factors at different chromosome ends22,46. RTEL1 deficiency did not affect the levels of mRNA transcribed from genes that are known to form R-loops59 or that of NRAS and BCL2 mRNAs, the 5’ UTRs of which form G-quadruplexes that are bound by RTEL1 in vitro (Supplementary Fig. 6C). We examined the cell cycle profile for these cells to exclude the possibility of differences in cell cycle accounting for fluctuations in TERRA levels60 (Supplementary Fig. 8). Cycling cells were stained with propidium iodide for DNA content and analyzed by flow cytometry. The Dean-Jett-Fox algorithm FlowJo™ was used to calculate the percentage of cells in each phase of the cell cycle G0–G1 phase (purple), S phase (yellow) and G2–M phase (green). Wild type RTEL1 cells have 44.1%, 34.2%, and 20.1% of cells in G1, S, and G2, respectively. RTEL-KO cells have a 30.3%, 33.7%, and 33.3% of cells in G1, S, and G2, respectively. These results suggest that cell cycle patterns alone do not account for TERRA fluctuations.

TERRA levels were also elevated in a panel of lymphoblastoid cell lines derived from HH and DC patients, as well as a fibroblast cell line homozygous for the RTEL1R1264H mutation. The lymphoblastoid lines examined were derived from a patient with HH harboring an autosomal dominant mutation, RTEL11010x/+ (NCI-164-1), the patient’s mother who presented with short telomeres but it is clinically unaffected (NCI-164-3), two cell lines from patients with HH due to with homozygous RTEL1 splice variants (RTEL1 c.2025+4A>C (NCI-323-1) and RTEL1 c.2142-7C>G (NCI-347-1)), and a DC patient cell line with a dyskerin mutation (DKC1K314R (NCI-106-3))15,16,61. Cells derived from a healthy donor proven negative for telomere biology gene mutations by exome sequencing (NCI-165-2) were used as the wild type control for lymphoblastoid cell lines, and a laboratory stock of previously immortalized BJ-hTERT’s were used as controls for RTEL1R1264H fibroblast cell lines as no healthy donor samples were available.

TERRA transcripts emanating from the same subtelomeric regions as in the RTEL1-KO line (i.e., 2q, 10q, 13q, and 21q) were elevated in cells derived from the RTEL11010x/+ proband, the proband’s mother, the RTEL1 c.2142-7C>G, and the DKC1K314R patient samples (Fig. 3e and Supplementary Fig. 9C–E). TERRA levels were also significantly elevated in a fibroblast cell line derived from a HH patient homozygous for the RTEL1R1264H allele15 (Fig. 3f). Conversely, TERRA levels were normal in the cells with the RTEL1 c.2025+4A>C mutation in which RTEL1 protein levels were not affected (Supplementary Fig. 9B), and TERRA transcripts emanating from chromosome 17p, which are regulated by CTCF binding30 were elevated in the DKC1K314R and RTEL1 c.2142-7C > G cell lines (Supplementary Fig. 9D). 2q, 10q, 13q, and 21q transcripts were unaffected in that cell line. These data suggest that alterations in TERRA levels associated with defects in RTEL1 may contribute to the disease phenotypes in HH and in DC.

In our hands, the RTEL1-KO cell line exhibits limited growth capacity and becomes senescent within one to two months, consistent with previous data62. Complementation with RTEL11-762, RTEL11-1118, RTEL1∆762, and RTEL1R1264H (Fig. 1a), failed to rescue the senescence phenotype, suggesting that both the TERRA-binding domain and the helicase domain are required for viability. However, complementation with wild type RTEL1 and the helicase deficient RTEL1K48R mutant permitted the establishment of viable clones (Supplementary Fig. 9A), suggesting that helicase activity per se is not essential.

Complementation of RTEL1-KO cells normalized TERRA levels in three independent transductions. Following introduction of wild type FLAG-RTEL1, TERRA levels decreased approximately ten-fold from all chromosomes tested (Fig. 4a and Supplementary Fig. 9A). TERRA levels were also reduced in FLAG-RTEL1K48R-expressing clones but remained significantly higher than cells complemented with wild type RTEL1 (Fig. 4a). RNA-seq analyses of wild type, RTEL1-KO HEK293 cells and cells complemented with FLAG-RTEL1 or FLAG-RTEL1K48R showed that subtelomeric read counts in the RTEL1-KO were elevated and reduced upon complementation with FLAG-RTEL1 or FLAG-RTEL1K48R (Fig. 4b). The magnitude of the increased read counts is less than observed in QPCR analyses, likely reflecting that TERRA increases were largely restricted to the four chromosome ends noted; RNA-seq represents an average high and low expression levels of TERRA coming from different chromosome ends. These results suggest that RTEL1 influences TERRA levels in a manner that is partially helicase dependent.

Fig. 4: RTEL1 Influences TERRA Localization.
figure4

TERRA levels are rescued upon RTEL1 complementation. a TERRA levels for four upregulated chromosome ends in the RTEL1-KO cell line were tested in cells complemented with FLAG-RTEL1 and a catalytic site mutant FLAG-RTEL1K48R. Bars represent the relative TERRA expression measured by qRT-PCR in three independent experiments (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, two-sided t-test) and mean and standard deviation is shown. b Total subtelomeric counts determined by RNA-seq experiments in the cell lines specified in a. Mean + /− SEM is shown. c Quantification of telomere loss per chromatid in FLAG-RTEL1 and FLAG-RTEL1K48R reconstituted cell lines by telomere FISH. d Representative telomere FISH images are shown with zoomed-in section (large white circle for zoom of small white circle). e Quantification of TERRA loss per chromatid in FLAG-RTEL1 and FLAG-RTEL1K48R reconstituted cell lines by TERRA FISH. f Representative TERRA FISH images are shown with zoomed-in section (large white circle for zoom of small white circle). Data for both TERRA and Telomere FISH experiments represent the average of at least 50 metaphases in each of three independent experiments and three independent reconstitutions shown as the mean and standard deviation (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, two-sided t-test) (see also Supplementary Figs. 8 and 9).

The normalization of TERRA levels in complemented cells was not correlated with restoration of telomeric DNA. We examined the levels of telomere loss in RTEL1-KO cells and cells complemented with FLAG-RTEL1 and FLAG-RTEL1K48R by Tel FISH. The frequency of telomeric signal free ends was only partially reduced in the reconstituted samples: 19%, 52%, 36%, and 45% for RTEL1 wild type, RTEL1-KO, FLAG-RTEL1, and FLAG-RTEL1K48R reconstitutions, respectively (Fig. 4c, d). These data argue that increased TERRA levels are not simply a consequence of telomere shortening.

To confirm that interpretation, we further examined the dependence of telomere length in TERRA R-loop formation using a sequential TERRA FISH-Tel FISH protocol63. Metaphase chromosomes from RTEL1 wild type and RTEL1-KO cells were subjected to two FISH staining steps. First, TERRA FISH was performed, then samples were destained, and conventional denaturing Tel FISH followed. Chromatid ends with clear Tel FISH signal were counted as “long telomeres” and scored for the corresponding TERRA signal in the same chromatids. The majority (75.2%) of long telomeres in the RTEL-KO cell line had TERRA free ends in comparison to 7.4% TERRA loss in the RTEL1 wild type cells (Fig. 5a). These data confirms that the increase in TERRA levels is not solely a consequence of telomere shortening, consistent with a role for RTEL1 in TERRA R-loop establishment and/or maintenance.

Fig. 5: RNAse H1 overexpression partially phenocopies RTEL1 deficiency.
figure5

a Example chromosomes, and quantitation of TERRA free ends per chromatid in Tel FISH-positive chromatid ends. Samples were processed by sequential TERRA-Tel FISH and scored for TERRA (red) in telomeres marked by Tel FISH signal (green). Chromatid ends in at least 25 metaphases in two experiments were counted (****p < 0.0001, two-sided t-test). TERRA levels are elevated after RNAse H1 overexpression. b TERRA levels of specified chromosome ends were tested in cells transfected with RNAse H1-GFP. Bars represent the relative TERRA expression measured by qRT-PCR in three independent experiments p-values are listed in Supplementary Fig. 10B (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, two-sided t-test). Means and standard deviation is shown. c Quantification of TERRA loss per chromatid in cells transfected with RNAse H1-GFP by TERRA FISH (22 days in selection). d Quantification of telomere loss per chromatid in cells transfected with RNAse H1-GFP by telomere FISH (22 days in selection). e Quantification of telomere loss per chromatid in cells transfected with RNAse H1-GFP by telomere FISH (52 days in selection). Three independent cell lines complemented with RTEL1 were averaged for analysis where specified. FISH experiments represent the average of at least 50 metaphases in each of 2 independent experiments and three independent reconstitutions shown as the mean and standard deviation (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, two-sided t-test) (see also Supplementary Fig. 10).

RTEL1 influences TERRA localization

We next examined TERRA localization in RTEL1-KO cells. TERRA is localized to telomeric regions within R-loop structures that are established co-transcriptionally or post-transcriptionally by insertion of TERRA in trans22,64. To assess whether TERRA’s telomeric localization was affected by RTEL1 deficiency, we carried out RNA FISH for TERRA on metaphase spreads of RTEL-KO cells and cells complemented with FLAG-RTEL1 and FLAG-RTEL1K48R by TERRA FISH (Fig. 4e, f). Specificity of the probe was confirmed by treatment with RNAses where most of the TERRA signal was abolished upon treatment. About 10% of the signal was resistant to RNAse treatments (Supplementary Fig. 7D). The level of TERRA free telomeres in wild type cells was 49.2%, while the majority of the RTEL1-KO chromatids (78.8%) had no detectable TERRA signal. Complementation with wild type RTEL1 reduced the number of TERRA free ends significantly, with the FLAG-RTEL1 having a greater impact than FLAG-RTEL1K48R (35.4% vs. 60% TERRA free ends).

Altogether, these data offer a different perspective on the role of RTEL1 and TERRA in stabilizing telomeric ends, suggesting that RTEL1 has a role in the establishment or stability of TERRA-containing R-loops while at the same time influencing the steady state levels of TERRA RNA.

These data raise the possibility of a relationship between TERRA R-loops and TERRA levels. Therefore, we targeted R-loops for destruction by overexpressing RNAse H1. RTEL1 wild type cells and RTEL-KO-FLAG-RTEL1-complemented cells were transfected with RNAse H1-GFP. Following 12 days of G418 selection, the selected pool of cells was assayed for RNAse H1-GFP expression (Supplementary Fig. 10A), and the levels of and localization of TERRA were assessed. We found that TERRA levels in the RNAse H1 expressing lines were significantly elevated, thus partially phenocopying RTEL1 deficiency (Figs. 5b, 3d, and Supplementary Fig. 10B). This outcome was not related to differences in cell cycle progression. Wild type (parental) and RTEL-KO cells reconstituted with wild type RTEL1 expressing RNAseH1 did not exhibit significant differences in growth profiles (Supplementary Fig. 8). These data argue that TERRA R-loops influence TERRA expression in wild-type cells.

As expected, the telomeric localization of TERRA, which is R-loop dependent, was also diminished after RNAse H1-GFP overexpression (Fig. 5c). The level of TERRA free ends in the wild type cells were 50%, while 68% of wild type RTEL1 cells with RNAse H1-GFP had no TERRA signal. Similarly, TERRA free ends were increased from 38% to 58% in FLAG-RTEL1 complemented RTEL-KO cells in which RNAse H1-GFP was overexpressed (Fig. 5c).

The frequency of telomeric signal free ends at 22 days post transfection was not significantly affected by RNAse H1-GFP overexpression: 23%, 23%, 36%, and 37% for RTEL1 wild type, RTEL1 wild type + RNAse H1-GFP, RTEL-KO-FLAG-RTEL1 and RTEL-KO-FLAG-RTEL1+RNAse H1-GFP, respectively (Fig. 5d). However, at 52 days, we observed a marked increase in the frequency of signal free telomeric ends; 24.8% vs. 35.3% for RTEL1 wild type compared to RTEL1 wild type+RNAse H1-GFP and 36.7%, vs. 50.2% in RTEL-KO-FLAG-RTEL1 and RTEL-KO-FLAG-RTEL1+RNAse H1-GFP. In contrast, no significant difference in TERRA levels was observed at this time point (Fig. 5e and Supplementary Fig. 10C).

Discussion

In this study, we established that RTEL1 influences the abundance and localization of the telomeric RNA TERRA, likely through direct binding to TERRA via a previously undescribed domain at the RTEL1 C-terminus. In vitro analyses revealed that RTEL1 binds G-quadruplex DNA and RNA, but the differential affinity for folded vs. unfolded RNA is significantly higher than for the analogous structures in DNA. In cells, RTEL1 hypomorphism and deficiency are associated with telomere fragility and loss, as noted previously1,6,15,56,57. However, we observed a marked increase in TERRA levels in RTEL1 deficient cells. Increased levels of TERRA was not associated with increased telomeric localization. Rather, in RTEL1 deficient cells, the frequency of TERRA occupancy at the telomeres of metaphase chromosomes was markedly reduced.

Reconstitution of RTEL-KO cells revealed that the effects on TERRA were only partially helicase dependent. We also found that RTEL1 cDNAs encoding RTEL1 variants that lacked the G4-binding domain were unable to support clonal survival of the RTEL1 knockout line, indicating the physiological importance of G4 engagement by RTEL1. The observation of elevated TERRA levels in RTEL1 knockout cells was recapitulated in several lymphoblastoid cell lines from HH and DC patients, as well as in a fibroblast line derived from the HH patient homozygous for the RTEL1R1264H allele15,16. In each of those cases, RTEL11010X, RTEL1R1264H, and the RTEL1c.2142-7C>G mutations predicted to alter splicing61, the RTEL1 C-terminus is affected (Figs. 1a and 3e, f). These data raise the possibility that telomere dysfunction may be caused by alterations of TERRA abundance and localization associated with RTEL1 deficiency, and this may contribute to the clinical phenotypes of DC and HH.

In addition to binding TERRA, the RTEL1 C-terminal domain promotes oligomerization via the C4 domain (Fig. 1c). In this regard, it is notable that some RTEL1 alleles behave as autosomal dominant mutations with respect to clinical presentation (RTEL11010X) or sub-clinically with respect to telomere length; the RTEL1R1264H heterozygous parents of homozygous RTEL1R1264H patients exhibit pronounced telomere shortening15,16,61. Supporting the importance of oligomerization, overexpression of RTEL1R1264H in wild type HEK293 cells leads to rapid selection against RTEL1R1264H expressing cells, whereas overexpression of RTEL1 cDNAs that encode proteins lacking the RING domain was well tolerated. Since the RTEL1 helicase domain is an independent oligomerization interface, the apparent toxicity of the RTEL1R1264H may reflect that RTEL1 assemblies in which the C-terminal homotypic interaction is impaired are toxic. The RING domain specifies functions aside from dimerization. For example, the interaction of RTEL1 with TRF2 is lost in the RTEL1R1264H mutant65; hence the apparent toxicity of RTEL1R1264H may not be due to an effect on dimerization. Nevertheless, these data support a model where both oligomerization and RNA binding are important for RTEL1 function independent of its helicase activity.

On the basis of the data obtained, we propose that the formation and maintenance of the TERRA R-loop at the telomere influences TERRA transcription and promotes telomere stability. In this conception, RTEL1 would be involved in either facilitating the creation of the TERRA-containing telomeric R-loop or contributing to its maintenance. Once established, the TERRA R-loop would limit further transcription from R-loop containing chromosome ends (Fig. 6). This part of the model is based on the reduction in TERRA R-loops and increased levels of TERRA in RTEL1 deficient cells (Figs. 3c–f and 4e, f). It is likely that the ability of RTEL1 to bind and discriminate distinct nucleic acid folds in vitro is biologically relevant at the telomere where these structures are predicted to form. Implicitly, the model also predicts that the presence of the R-loop at the telomere contributes to telomere stability.

Fig. 6: RTEL1 Influences the Abundance and Localization of the Telomeric RNA TERRA.
figure6

The formation and maintenance of the TERRA R-loop at the telomere influences TERRA transcription and promotes telomere stability. We propose RTEL1 would be involved in either facilitating the creation or contributing to the maintenance of the TERRA-containing telomeric R-loop. Once established, the TERRA R-loop would limit further transcription from R-loop containing chromosome ends.

The phenotypic outcomes of RNAse H1 overexpression, which is known to disrupt R-loops43, were consistent with the model proposed. First, RNAse H1 overexpression increased the frequency of metaphase chromosomes that lacked TERRA FISH signal. This apparent reduction in TERRA R-loops was associated with increased levels of TERRA RNA, as inferred by Q-PCR. Notably, RNAse H1 overexpression increased TERRA levels from chromosomes 2q, 10q, 13q, and 21q (Fig. 5b), but not chromosomes 8p, 19p, or Xq (Fig. 5b). Transcription of TERRA from those same chromosomes also increases upon RTEL1 inactivation and in hypomorphic patient cells (Fig. 3d–f and Supplementary Fig. 9C, D), strengthening the idea that the R-loop exerts an influence on TERRA abundance, at least from those telomeric loci.

Second, the model predicts that the TERRA R-loop would contribute to telomere stability, and accordingly that RNAse H1 overexpression would decrease telomere stability. At 12 and 22 days after transfection of RNAse H1, R-loops, as inferred from TERRA RNA FISH, were diminished but no increase in telomere-free chromatid ends was evident, consistent with previous data (ref. 43 and Fig. 5c, d). As noted above, TERRA levels were elevated at those time points. At 52 days post transfection, a significant increase in telomere loss was evident (Fig. 5e), again consistent with the model.

However, at the 52 day time point, TERRA levels were no longer elevated. On its face, this observation is inconsistent with the simplest interpretation of the model, but it is conceivable that prolonged RNAse H1 overexpression may exert an indirect effect on TERRA expression. R-loops have been shown to prevent methylation of promoters by excluding binding of a methyltransferase required for proper gene silencing66. Some TERRA promoters are regulated by DNA methylation and depletion of, or defects in methyltransferases lead to elevated TERRA levels22,31,67. TERRA also interacts with ATRX, and antagonizes its functions24. Hence it is also conceivable that prolonged absence of TERRA-containing R-loops allows ATRX-mediated silencing of TERRA promoters. TERRA expression may also be reduced in an R-loop independent manner.

The role of RTEL1 in regulating R-loops is likely to be complex, and may involve both negative and positive regulation of those structures, likely through its binding to G4 structures. R-loops are associated with GC rich genomic contexts59 and recent data suggest that RTEL1 dismantles R-loops at loci in which G-quadruplex forming sequences are common, including those within common fragile sites10.

On the other hand, there is precedent for G4-binding helicases promoting the post-transcriptional formation of R-loop structures. For example, immunoglobulin class switch regions are G-rich repetitive elements that must be transcribed in order for class switch recombination to occur. Debranching of the spliced switch region transcript and its subsequent insertion into an R-loop structure requires the action of DDX1, an RNA helicase that binds the G4 structure of the transcript and inserts the RNA into the switch region DNA duplex to form the R-loop structure required for class switch recombination68,69. In addition, it is clear that TERRA can be inserted into R-loop structures in trans24,29,64, although the helicase required and whether it depends on G4 structure is not known.

The model proposed here wherein RTEL1 promotes telomere stability via its influence on the localization and abundance of TERRA RNA does not exclude other models to explain the role of RTEL1 in stabilizing the telomere. A prevalent model suggests that RTEL1 disassembles T-loops to allow DNA replication to proceed to the chromosome end6,56. When RTEL1 is depleted the T-loops are persistent and inappropriately resolved by the SLX4 nuclease. Loss of RTEL1-dependent resolution of the T-loop or other secondary structures has also been suggested to promote replication fork reversal upstream of the secondary structure obstacle. This pathological situation is proposed to be stabilized by binding of the TERT protein to the reversed fork and again lead to cleavage by SLX45.

These models account for the detection of extrachromosomal telomeric circles, and for telomere fragility. A prediction of these models is that telomere loss should be identical on both sister chromatids, since the SLX4 cleavage event occurs before replication. Based on telomere FISH, this is true for a subset of chromosomes, but loss of telomeric signal on one sister chromatid is often observed (refs. 6,15,56 and Fig. 4d herein). This signal heterogeneity suggests that there may be more than one mechanism for how the telomeres are maintained by RTEL1, with some loss of telomeric sequences arising via the model proposed here (Fig. 6). Additionally, a new report suggests that rapid telomere deletion in the form of T-circles may not cause telomere shortening in an RTEL1 deficient setting70. T-circle formation varied according to telomerase status, cell type and RTEL1 function70.

Recruitment of TERRA to short telomeres has been described in yeast and mammalian cells where it is suggested to help maintain telomeres by promoting recombination or recruitment of telomere maintenance factors like telomerase41,44,64. Telomeres are proposed to have either the ability to retain more TERRA when they are short or have active removal of TERRA RNA in a setting with long telomeres64. Furthermore a RAD51-mediated strand-invasion-like reaction was shown to be required for the insertion of TERRA R-loops into the telomere repeats and the resulting R-loops are sensitive to RNAse H164. The mechanistic steps and totality of factors that are involved in forming and maintaining the TERRA R-loop remain unknown.

The data presented herein suggest a mechanism to account for RTEL1’s influence on telomere stability, and may illuminate the biological significance of RTEL1–TERRA interaction. The data further support the view that TERRA plays a role in stabilizing telomeric sequences.

Methods

Cell lines

HEK293 and HEK293T cells were grown in 10% DMEM and 10% FBS. EBV-immortalized lymphoblastoid cell lines were derived from participants in the National Cancer Institute’s IRB-approved longitudinal cohort study entitled “Etiologic Investigation of Cancer Susceptibility in Inherited Bone Marrow Failure Syndromes” (ClinicalTrials.gov Identifier: NCT00027274)71. This study includes comprehensive family history and individual history questionnaires, detailed medical record review, and biospecimen collection. Detailed clinical evaluations were performed at the NIH Clinical Center per protocol. LCLs were grown in RPMI Media supplemented with 100 U/ml penicillin, 100 μg/ml streptomycin, GlutaMAX (Life Technologies), and 20% FBS. hTERT transduced fibroblasts were cultured in DMEM media supplemented with 100 U/ml penicillin, 100 μg/ml streptomycin, GlutaMAX, and 15% FBS. All cell lines used were routinely checked for mycoplasma.

Protein expression and purification

Sequences encoding residues 762-1300, 762-1097, 1097-1300, 1118-1300, and 1143-1300 of human RTEL1 were amplified by PCR then subcloned between the EcoRI and XhoI restriction sites of pET28 (Novagen). RTEL1 proteins were expressed as 6-histidine-fusions in the E. coli strain BL21 and purified using His-trap (GE Healthcare), Hi-Trap Q (GE Healthcare), and Superdex 200 columns (GE Healthcare). For expression in mammalian cells, full-length human RTEL1 and RTEL11-1097 were subcloned in to pcDNA3.1 MCS-BirA (R118G)-HA between HpaI and EcoR1 sites. pcDNA3.1 MCS-BirA(R118G)-HA was a gift from Kyle Roux (Addgene plasmid # 36047). Full-length RTEL1 was cloned into pDest12.2-myc-his and pDESTb-FRT-C3xFLAG. RTEL1∆1097 was amplified by PCR and subcloned between EcoRI and XhoI restriction sites of pCDNA3.1_FLAG-HA (Invitrogen) and pIC113 (Addgene plasmid # 44434). For expression of RTEL1 proteins in HEK293 RTEL1-KO cells, full-length human RTEL1 was cloned into pLenti-C-myc-DDK-IRES-Puro (Origene) plasmid by digestion with AscI and MIuI and mutagenesis for RTEL1K48R was performed using QuikChange Lightning Multi Site-Directed Mutagenesis Kit (Agilent). Cells were infected with lentiviruses expressing the indicated RTEL1 proteins and infected cells were selected with puromycin as previously described72. Cell lines derived from three independent infections were used for reconstitution experiments. The pEGFP‐RNAse H1 was a gift from Andrew Jackson & Martin Reijns (Addgene plasmid # 108699). HEK293 were transfected using PEI-25K (polysciences Inc.) and after 48 h selected with G418 for the indicated time points. For RNA-IP experiments FLAG-RTEL1, FLAG-∆762 were cloned into pCMV6-AC-DDK (Origene) plasmid and FLAG-TRF1 was a gift from Titia de Lange (Addgene plasmid # 16058).

Co-immunoprecipitation and western blotting

HEK293T cells were transfected with wild type and single point mutants of the following constructs as indicated: RTEL1-myc-HIS, RTEL1-FLAG, GFP-RTEL1∆1097, and FLAG-HA RTEL1∆1097 using PEI-25K (polysciences Inc.). An additional nuclear localization signal (MADPKKKRK) was added to the 5’ end of the RTEL1 truncation constructs and mutagenesis was performed using standard protocols. Cell extracts were prepared using 1X PBS, 0.5% (v/v) Triton-X-100 and protease inhibitor tablet (Sigma). Proteins were immunoprecipitated by incubating cell extracts overnight with either FLAG M2 (Sigma) or GFP (Clonetech) antibodies at 4 °C, followed by incubation with Protein A/G beads for 3 h. Lentiviral transfections were performed as previously described52. Western blotting was performed using standard methods. Total extracts were prepared in lysis buffer (60 mM Tris-HCl pH 6.8, 2% SDS) and analyzed with specified antibodies. The antibodies used in this study were GFP JL-8 (Clonetech, 632381, 1:4000), ANTI-FLAG® M2 (Sigma, F1804, 1:1000), HA (Biolegend #901515, 1:1000), myc 9E10 (BioXcell, BE0238, 1:4000), RTEL1 (custom made 1:2000–5000), Actin-HRP (ABCAM, ab49900 1:50,000), GAPDH (Santacruz, sc_32233, 1:1000) and RNAse H1 (Proteintech 15606-1-AP, 1:1000).

Size exclusion chromatography coupled to multi-angle light scattering (SEC-MALS)

The molar masses of RTEL1 proteins were analyzed using SEC-MALS. In all, 200–300 µg of the indicated proteins were injected into a Superdex 200 10/300 GL (GE Healthcare) equilibrated at a flow rate of 0.3 ml per minute in 50 mM Hepes pH 7.5, 1 mM TCEP, and either 150 or 300 mM NaCl. Light scattering was monitored with a miniDAWNTREOS system (Wyatt Technology), concentration was measured with the Optilab T-rEX differential refractometer (Wyatt Technology), and molar masses were calculated using the Astra 6.1 program (Wyatt Technology) with a dn/dc value of 0.185 ml/g.

BioID

Affinity purification of biotinylated proteins was performed as previously described47. Briefly cells were supplemented with 50 µM biotin for 24 h and sonicated in lysis buffer containing 50 mM Tris, pH 7.4, 500 mM NaCl, 0.4% SDS, 5 mM EDTA, 1 mM DTT, 1x Complete protease inhibitor (Roche). Triton-X-100 was brought up to 2% and an equal volume of 50 mM Tris, pH 7.4 was added before clarifying the lysate by centrifugation. Supernatants were incubated with 200 µl Dynabeads (MyOne Steptavadin C1; Invitrogen) overnight. The beads were washed with 1.5 ml wash buffer 1 (2% SDS), 1.5 wash buffer 2 (0.1% deoxycholate, 1% Triton-X-100, 500 mM NaCl, 1 mM EDTA, and 50 mM Hepes, pH 7.5), 1.5 ml wash buffer 3 (250 mM LiCl, 0.5% NP-40, 0.5% deoxycholate, 1 mM EDTA, and 10 mM Tris, pH 8.1). After the wash 1.5 ml (50 mM Tris, pH 7.4, and 50 mM NaCl) and 50 µl 50 mM NH4HCO3 were added before mass spectrometry analysis. On- bead tryptic digestions were analyzed by the MSKCC Proteomics Core as previously described47. MassHunter Qualitative Analysis software (Agilent Technologies) was used to analyze the raw data and database search was done using MASCOT (MatrixScience). SCAFFOLD Q + (Proteome Software) was used to visualize the data with a threshold of at least 2 identified peptides and a minimum 95% probability each.

Binding assays

Oligonucleotides were refolded in 10 mM Tris pH 7.5 and 100 mM KCL (unless otherwise noted) with slow cooling starting at 95 °C down to room temperature. The change in fluorescence anisotropy of the indicated 5’ fluorescein labeled oligonucleotides was measured to determine the relative binding affinities of RTEL1 proteins. The labeled oligonucleotides were mixed in 20 μl reaction volumes with the indicated RTEL1 proteins at concentrations ranging from 0 to 5 μM (unless otherwise indicated) in a reaction buffer containing 20 mM Tris, pH 7.5, 50 mM KCl, 0.5 mM TCEP, 0.5 mM MgCl2, 10% glycerol, and 0.1% IGEPAL in a 384-well microplate. The binding data were collected on a SpectraMax M5 (Molecular Devices) using a 495 nm excitation wavelength and a 525 nm emission wavelength. Apparent KD values were calculated from triplicate experiments using a model for receptor depletion and plotted using Prism 7 GraphPad Software. The model used was: Y = Af + (Ab − Af)*((L + Kd + X) − sqrt((sqr( − L − Kd − X)) − 4*L*X))/(2*L). Where A is the anisotropy measured; Ab is the anisotropy at saturation (100%), Af is the anisotropy of the free oligonucleotide, L is the fixed concentration of the oligonucleotide and X is the protein concentration. For competition assays, RTEL1-FAM-TERRA-MUT (wild type TERRA RNA was not readily competed by any of the oligonucleotides tested) complex concentration was maintained at 200 nM or 1 µM as indicated. Competitor oligonucleotides were added at concentrations ranging from 0 to 20 µM as specified. Experiments were performed in triplicate, and the data were fit to a one-site-binding model for competition assays using Prism 7. For EMSA (Electrophoretic mobility shift assay), binding reactions were performed in buffer containing 20 mM Tris, pH 7.5, 50 mM KCl, 0.5 mM TCEP, 0.5 mM MgCl2, 10% glycerol, and 0.1% IGEPAL. RTEL1 proteins and 5’ FAM- labeled oligonucleotide at the indicated concentrations were incubated at room temperature for 30 min then loaded onto a 4–20% polyacrylamide non-denaturing gel. The gels were imaged using fluorescein fluorescence on a Typhoon FLA9500 instrument (GE).

Quantitative reverse transcription PCR (RT-qPCR)

Total RNA was extracted from the specified cell lines using the RNeasy Mini Kit (Qiagen) with DNase treatment. cDNA was synthesized using Superscript IV kit (Invitrogen) using random primers. TERRA expression in each sample was normalized to GAPDH and relative expression was determined with the comparative CT method. Primers used in this study are listed in Supplementary Table 1.

DNA and RNA FISH

Metaphase chromosome spreads were prepared by incubating cells with 0.1 µg/µl KaryoMAX colcemid solution for 90 min. Cells were harvested at 1000 rpm and resuspended in 0.075 M KCL at 37 °C for 15 min. Cells were fixed in a 3:1 mixture of ice-cold methanol/acetic acid at least overnight and spread onto glass slides then air dried overnight. Samples were treated with 100 µg/ml RNAse A (Sigma) for 1 h at 37 °C, dehydrated through a series of ethanol washes at 70%, 90%, and 100% ethanol for 5 min each at room temperature, then allowed to air dry. Hybridization was in buffer containing 10 mM Tris pH 7.5, 70% formamide, 0.5% blocking reagent (Roche) and 0.5 µg/ml CY-3 (CCCTAA)3 or Alexa 488 (GGGTAA)3 (PNA BIO), denatured at 75 °C for 5 min and incubated at room temperature for 16 h. Slides were washed twice in buffer containing 10 mM Tris pH 7.5, 0.1% BSA, and 70% formamide, then three times in PBS/0.15% Triton-X-100. The slides were mounted using proLong Gold antifade reagent with DAPI (Invitrogen). For TERRA FISH, slides were treated with either 100U RNAse H1 (NEB) alone or a mixture of RNAse A and RNAse H1 in PBS and 1x RNAseH1 buffer for specificity controls, or in buffer without RNAses for at least 6 h then treated as above with the exception of the denaturation step. Sequential FISH was performed as previously described63. Briefly, metaphase spreads were first stained by TERRA FISH. Images were collected and coordinates were recorded for selected metaphases. Samples were subsequently destained by washing with PBS then 2x SSC. The same slides were then processed for Tel FISH and images of the pre- recorded metaphases were captured. Metaphases were scored for Tel FISH and TERRA FISH to determine TERRA loss at chromatid ends with clear Tel FISH signal. Images were acquired on a Deltavision Imaging Elite System (GE Healthcare) with a CMOS Camera on an Olympus IX-71 microscope using a 60x objective. Images were analyzed using ImageJ and statistical analysis was done with Prisim 7 (Graphpad).

Generation of the RTEL1 knockout line

RTEL1 knockout was performed using CRISPR-Cas9-mediated genome editing as described previously55. We used a guide RNA mapping to Exon 2 of the RTEL1 gene 5′-TGCCCGCAAGATTGCCGAGA. PCR-genotyping was performed using the following primers: 5′- GGGACTTGCCTGTGGACTTCTCCGC and 5′-CGCCATCCCTTGCCAACCATCCCC. PCR products were cloned using the Zero Blunt PCR Cloning Kit (Thermo Fisher Scientific, K270040) and 20 clones were sequenced per cell line to verify successful genome editing. Cells were grown from single cell clones until enough material was available for experiments ~2.5+ months.

RNA crosslinking and RNA-IP

To analyze the RNA crosslinking capacity of wild type and mutant RTEL1 proteins, RTEL1-KO cells were complemented with N-terminally FLAG-HA-tagged wild type or mutant RTEL1. Cells were fed with 4-thiouridine (100 M) for 16 h and crosslinked at 365 nm. A modified version of PAR-CLIP52 was performed using a single RNase A digestion step and using anti-FLAG-M2 magnetic beads (Sigma, M8823) for IP.

RNA immunoprecipitation, RNA purification, DNAse treatment, RNAse treatment and slot blotting was performed as previously described53 with the following modifications: HEK293T cells were transfected with FLAG-RTEL1, FLAG-∆762 and FLAG-TRF1 using PEI-25K (polysciences Inc.). Flag M2 beads (Sigma) were pre-incubated overnight with 1% BSA in PBS before IP. TERRA probe containing 800 bp TTAGGG repeats was obtained by NotI/SacII restriction digest and pSXneo 135(T2AG3) Addgene (#12402). A 554 bp long cMYC probe was generated by BamHI/SacII digest of pCDNA3- cMYC (addgene #16011). Probes were random prime radiolabeled (α32P-dCTP) using the Amersham Megaprime DNA Labeling System (cytiva) following the manufacturers instructions. After UV crosslinking and baking the membrane at 65 °C for 1 h, the membrane was prehybridized at 50 °C for 1 h in 10 ml ULTRAhyb buffer (Thermo Fisher Scientific). The probes were denatured for 5 min at 95 °C prior addition to the hybridization tubes. Following hybridization over night at 50 °C, the membranes were washed five times for 30 min with 2xSSC and 0.1% SDS at 50 °C. The images were scanned followed by quantification with ImageGauge software (GE Healthcare).

RNA-seq analysis for subtelomere counts

RNAseq libraries were prepared from total RNA using ribosomal RNA depletion method. Paired-end reads were aligned using STAR against subtelomeric sequences (subtelomeric sequences cover 15 kb before the start of the telomeric sequences TTAGGG for 1p,1q,2p,2q,3p,3q,4p,4q,5p,5q,6p,6q,7p,7q,8p,8q,9p,9q,10p,10q,11q,12p, 12q,13q,14q,15q,16p,16q,17p,17q,18p,18q,19p,19q,10p,10q,21q,22q,Xp,Xq.Yq ends and were provided by Dr. Joachim Linger). Mapped reads were counted using Featurecounts, allowing multi-mapping reads, and counting each alignment fractionally. The raw total counts of all the subtelomeric sequences for each sample were normalized using size factors from DESeq2. The size factors were generated from the whole transcriptome analysis for the same samples.

Flow cytometry

Cell cycle analysis was performed by flow cytometry. Cells were fixed, RNase treated, and stained with propidium iodide. Data were analyzed with FlowJo™ software and percentages of cells in different stages of the cell cycle were calculated using the Dean-Jet-Fox model. G0–G1 phase (purple), S phase (yellow) and G2–M phase (green). Percentages of each phase are listed below each plot.

Statistics

At least three independent experiments were carried out for each data set unless otherwise stated. Error bars, the number of replicates and p-values are shown in the figures and legends. All data was represented and statistically analyzed with Prism7 using two-tailed Student’s t-tests where indicated.

Reporting summary

Further information on research design is available in the Nature Research Reporting Summary linked to this article.

Data availability

Data from this study are available from the corresponding author upon reasonable request. Source data are provided with this paper.

References

  1. 1.

    Uringa, E. J., Youds, J. L., Lisaingo, K., Lansdorp, P. M. & Boulton, S. J. RTEL1: an essential helicase for telomere maintenance and the regulation of homologous recombination. Nucleic Acids Res. 39, 1647–1655 (2011).

    CAS  PubMed  Article  Google Scholar 

  2. 2.

    Wu, Y. & Brosh, R. M. Jr. DNA helicase and helicase-nuclease enzymes with a conserved iron-sulfur cluster. Nucleic Acids Res. 40, 4247–4260 (2012).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  3. 3.

    Bai, C. et al. Overexpression of M68/DcR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a four-gene cluster. Proc. Natl Acad. Sci. USA 97, 1230–1235 (2000).

    ADS  CAS  PubMed  Article  Google Scholar 

  4. 4.

    Ding, H. et al. Regulation of murine telomere length by Rtel: an essential gene encoding a helicase-like protein. Cell 117, 873–886 (2004).

    CAS  PubMed  Article  Google Scholar 

  5. 5.

    Margalef, P. et al. Stabilization of reversed replication forks by telomerase drives telomere catastrophe. Cell 172, 439–453 e414 (2018).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  6. 6.

    Sarek, G., Vannier, J. B., Panier, S., Petrini, J. H. & Boulton, S. J. TRF2 recruits RTEL1 to telomeres in S phase to promote t-loop unwinding. Mol. Cell 57, 622–635 (2015).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  7. 7.

    Vannier, J. B. et al. RTEL1 is a replisome-associated helicase that promotes telomere and genome-wide replication. Science 342, 239–242 (2013).

    ADS  CAS  PubMed  Article  Google Scholar 

  8. 8.

    Olivier, M., Charbonnel, C., Amiard, S., White, C. I. & Gallego, M. E. RAD51 and RTEL1 compensate telomere loss in the absence of telomerase. Nucleic Acids Res. 46, 2432–2445 (2018).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  9. 9.

    Minocherhomji, S. et al. Replication stress activates DNA repair synthesis in mitosis. Nature 528, 286–290 (2015).

    ADS  CAS  PubMed  Article  Google Scholar 

  10. 10.

    Wu, W. et al. RTEL1 suppresses G-quadruplex-associated R-loops at difficult-to-replicate loci in the human genome. Nat. Struct. Mol. Biol. 27, 424–437 (2020).

  11. 11.

    Schertzer, M. et al. Human regulator of telomere elongation helicase 1 (RTEL1) is required for the nuclear and cytoplasmic trafficking of pre-U2 RNA. Nucleic Acids Res. 43, 1834–1847 (2015).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  12. 12.

    Niewisch, M. R. & Savage, S. A. An update on the biology and management of dyskeratosis congenita and related telomere biology disorders. Expert Rev. Hematol. 12, 1037–1052 (2019).

    CAS  PubMed  Article  Google Scholar 

  13. 13.

    Bertuch, A. A. The molecular genetics of the telomere biology disorders. RNA Biol. 13, 696–706 (2016).

    PubMed  Article  Google Scholar 

  14. 14.

    Faure, G., Revy, P., Schertzer, M., Londono-Vallejo, A. & Callebaut, I. The C-terminal extension of human RTEL1, mutated in Hoyeraal-Hreidarsson syndrome, contains Harmonin-N-like domains. Proteins, https://doi.org/10.1002/prot.24438 (2013).

  15. 15.

    Ballew, B. J. et al. A recessive founder mutation in regulator of telomere elongation helicase 1, RTEL1, underlies severe immunodeficiency and features of Hoyeraal Hreidarsson syndrome. PLoS Genet. 9, e1003695 (2013).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  16. 16.

    Ballew, B. J. et al. Germline mutations of regulator of telomere elongation helicase 1, RTEL1, in Dyskeratosis congenita. Hum. Genet. 132, 473–480 (2013).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  17. 17.

    Borie, R. et al. Regulator of telomere length 1 (RTEL1) mutations are associated with heterogeneous pulmonary and extra-pulmonary phenotypes. Eur. Respir. J. 53, 1800508 (2019).

  18. 18.

    Touzot, F. et al. Extended clinical and genetic spectrum associated with biallelic RTEL1 mutations. Blood Adv. 1, 36–46 (2016).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  19. 19.

    Newton, C. A. et al. Telomere-related lung fibrosis is diagnostically heterogeneous but uniformly progressive. Eur. Respir. J. 48, 1710–1720 (2016).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  20. 20.

    Azzalin, C. M., Reichenbach, P., Khoriauli, L., Giulotto, E. & Lingner, J. Telomeric repeat containing RNA and RNA surveillance factors at mammalian chromosome ends. Science 318, 798–801 (2007).

    ADS  CAS  PubMed  Article  Google Scholar 

  21. 21.

    Schoeftner, S. & Blasco, M. A. Developmentally regulated transcription of mammalian telomeres by DNA-dependent RNA polymerase II. Nat. Cell Biol. 10, 228–236 (2008).

    CAS  PubMed  Article  Google Scholar 

  22. 22.

    Feretzaki, M., Renck Nunes, P. & Lingner, J. Expression and differential regulation of human TERRA at several chromosome ends. RNA https://doi.org/10.1261/rna.072322.119 (2019).

  23. 23.

    Fedick, A. M. et al. Carrier screening of RTEL1 mutations in the Ashkenazi Jewish population. Clin. Genet. 88, 177–181 (2015).

    CAS  PubMed  Article  Google Scholar 

  24. 24.

    Chu, H. P. et al. TERRA RNA antagonizes ATRX and protects telomeres. Cell 170, 86–101 (2017). e116.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  25. 25.

    Porro, A. et al. Functional characterization of the TERRA transcriptome at damaged telomeres. Nat. Commun. 5, 5379 (2014).

    ADS  CAS  PubMed  PubMed Central  Article  Google Scholar 

  26. 26.

    Balk, B. et al. Telomeric RNA-DNA hybrids affect telomere-length dynamics and senescence. Nat. Struct. Mol. Biol. 20, 1199–1205 (2013).

    CAS  PubMed  Article  Google Scholar 

  27. 27.

    Aguilera, A. & Garcia-Muse, T. R loops: from transcription byproducts to threats to genome stability. Mol. Cell 46, 115–124 (2012).

    CAS  PubMed  Article  Google Scholar 

  28. 28.

    Lopez de Silanes, I., Stagno d’Alcontres, M. & Blasco, M. A. TERRA transcripts are bound by a complex array of RNA-binding proteins. Nat. Commun. 1, 33 (2010).

    ADS  PubMed  Article  CAS  Google Scholar 

  29. 29.

    Lee, Y. W., Arora, R., Wischnewski, H. & Azzalin, C. M. TRF1 participates in chromosome end protection by averting TRF2-dependent telomeric R loops. Nat. Struct. Mol. Biol. 25, 147–153 (2018).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  30. 30.

    Beishline, K. et al. CTCF driven TERRA transcription facilitates completion of telomere DNA replication. Nat. Commun. 8, 2114 (2017).

    ADS  PubMed  PubMed Central  Article  CAS  Google Scholar 

  31. 31.

    Sagie, S. et al. Telomeres in ICF syndrome cells are vulnerable to DNA damage due to elevated DNA:RNA hybrids. Nat. Commun. 8, 14015 (2017).

    ADS  CAS  PubMed  PubMed Central  Article  Google Scholar 

  32. 32.

    Takai, H., Smogorzewska, A. & de Lange, T. DNA damage foci at dysfunctional telomeres. Curr. Biol. 13, 1549–1556 (2003).

    CAS  Article  Google Scholar 

  33. 33.

    Eid, R. et al. Genetic inactivation of ATRX leads to a decrease in the amount of telomeric cohesin and level of telomere transcription in human glioma cells. Mol. Cell Biol. 35, 2818–2830 (2015).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  34. 34.

    Nguyen, D. T. et al. The chromatin remodelling factor ATRX suppresses R-loops in transcribed telomeric repeats. EMBO Rep. 18, 914–928 (2017).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  35. 35.

    Sen, D. & Gilbert, W. Formation of parallel four-stranded complexes by guanine-rich motifs in DNA and its implications for meiosis. Nature 334, 364–366 (1988).

    ADS  CAS  PubMed  Article  Google Scholar 

  36. 36.

    Biffi, G., Tannahill, D. & Balasubramanian, S. An intramolecular G-quadruplex structure is required for binding of telomeric repeat-containing RNA to the telomeric protein TRF2. J. Am. Chem. Soc. 134, 11974–11976 (2012).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  37. 37.

    Bao, H. L. et al. Characterization of human telomere RNA G-quadruplex structures in vitro and in living cells using 19F NMR spectroscopy. Nucleic Acids Res. 45, 5501–5511 (2017).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  38. 38.

    Hansel-Hertsch, R., Di Antonio, M. & Balasubramanian, S. DNA G-quadruplexes in the human genome: detection, functions and therapeutic potential. Nat. Rev. Mol. Cell Biol. 18, 279–284 (2017).

    CAS  PubMed  Article  Google Scholar 

  39. 39.

    Guo, J. U. & Bartel, D. P. RNA G-quadruplexes are globally unfolded in eukaryotic cells and depleted in bacteria. Science 353, https://doi.org/10.1126/science.aaf5371 (2016).

  40. 40.

    Graf, M. et al. Telomere length determines TERRA and R-loop regulation through the cell cycle. Cell 170, 72–85 e14 (2017).

    CAS  PubMed  Article  Google Scholar 

  41. 41.

    Moravec, M. et al. TERRA promotes telomerase-mediated telomere elongation in Schizosaccharomyces pombe. EMBO Rep. 17, 999–1012 (2016).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  42. 42.

    Lopez de Silanes, I. et al. Identification of TERRA locus unveils a telomere protection role through association to nearly all chromosomes. Nat. Commun. 5, 4723 (2014).

    ADS  CAS  PubMed  Article  Google Scholar 

  43. 43.

    Arora, R. et al. RNaseH1 regulates TERRA-telomeric DNA hybrids and telomere maintenance in ALT tumour cells. Nat. Commun. 5, 5220 (2014).

    ADS  CAS  PubMed  PubMed Central  Article  Google Scholar 

  44. 44.

    Cusanelli, E., Romero, C. A. & Chartrand, P. Telomeric noncoding RNA TERRA is induced by telomere shortening to nucleate telomerase molecules at short telomeres. Mol. Cell 51, 780–791 (2013).

    CAS  PubMed  Article  Google Scholar 

  45. 45.

    Pfeiffer, V. & Lingner, J. TERRA promotes telomere shortening through exonuclease 1-mediated resection of chromosome ends. PLoS Genet. 8, e1002747 (2012).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  46. 46.

    Deng, Z. et al. A role for CTCF and cohesin in subtelomere chromatin organization, TERRA transcription, and telomere end protection. EMBO J. 31, 4165–4178 (2012).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  47. 47.

    Roux, K. J., Kim, D. I., Raida, M. & Burke, B. A promiscuous biotin ligase fusion protein identifies proximal and interacting proteins in mammalian cells. J. Cell Biol. 196, 801–810 (2012).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  48. 48.

    Kim, D. I. et al. Probing nuclear pore complex architecture with proximity-dependent biotinylation. Proc. Natl Acad. Sci. USA 111, E2453–E2461 (2014).

    CAS  PubMed  Article  Google Scholar 

  49. 49.

    Petti, E. et al. SFPQ and NONO suppress RNA:DNA-hybrid-related telomere instability. Nat. Commun. 10, 1001 (2019).

    ADS  PubMed  PubMed Central  Article  CAS  Google Scholar 

  50. 50.

    Yangyuoru, P. M. et al. Mechanochemical properties of individual human telomeric RNA (TERRA) G-quadruplexes. Chembiochem 14, 1931–1935 (2013).

    CAS  PubMed  Article  Google Scholar 

  51. 51.

    Safaee, N. et al. Structure of the parallel duplex of poly(A) RNA: evaluation of a 50 year-old prediction. Angew. Chem. 52, 10370–10373 (2013).

    CAS  Article  Google Scholar 

  52. 52.

    Garzia, A., Meyer, C., Morozov, P., Sajek, M. & Tuschl, T. Optimization of PAR-CLIP for transcriptome-wide identification of binding sites of RNA-binding proteins. Methods 118-119, 24–40 (2017).

    CAS  PubMed  Article  Google Scholar 

  53. 53.

    Deng, Z., Norseen, J., Wiedmer, A., Riethman, H. & Lieberman, P. M. TERRA RNA binding to TRF2 facilitates heterochromatin formation and ORC recruitment at telomeres. Mol. Cell 35, 403–413 (2009).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  54. 54.

    Calabrese, D. R. et al. Chemical and structural studies provide a mechanistic basis for recognition of the MYC G-quadruplex. Nat. Commun. 9, 4229 (2018).

    ADS  PubMed  PubMed Central  Article  CAS  Google Scholar 

  55. 55.

    Ran, F. A. et al. Genome engineering using the CRISPR-Cas9 system. Nat. Protoc. 8, 2281–2308 (2013).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  56. 56.

    Vannier, J. B., Pavicic-Kaltenbrunner, V., Petalcorin, M. I., Ding, H. & Boulton, S. J. RTEL1 dismantles T loops and counteracts telomeric G4-DNA to maintain telomere integrity. Cell 149, 795–806 (2012).

    CAS  PubMed  Article  Google Scholar 

  57. 57.

    Le Guen, T. et al. Human RTEL1 deficiency causes Hoyeraal-Hreidarsson syndrome with short telomeres and genome instability. Hum. Mol. Genet. 22, 3239–3249 (2013).

    PubMed  Article  CAS  Google Scholar 

  58. 58.

    Feretzaki, M. & Lingner, J. A practical qPCR approach to detect TERRA, the elusive telomeric repeat-containing RNA. Methods 114, 39–45 (2017).

    CAS  PubMed  Article  Google Scholar 

  59. 59.

    Sanz, L. A. et al. Prevalent, dynamic, and conserved r-loop structures associate with specific epigenomic signatures in mammals. Mol. Cell 63, 167–178 (2016).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  60. 60.

    Porro, A., Feuerhahn, S., Reichenbach, P. & Lingner, J. Molecular dissection of telomeric repeat-containing RNA biogenesis unveils the presence of distinct and multiple regulatory pathways. Mol. Cell Biol. 30, 4808–4817 (2010).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  61. 61.

    Ungar, R. A. et al. Complex phenotype of dyskeratosis congenita and mood dysregulation with novel homozygous RTEL1 and TPH1 variants. Am. J. Med. Genet. A 176, 1432–1437 (2018).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  62. 62.

    Barber, L. J. et al. RTEL1 maintains genomic stability by suppressing homologous recombination. Cell 135, 261–271 (2008).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  63. 63.

    Roumelioti, F. M. et al. Alternative lengthening of human telomeres is a conservative DNA replication process with features of break-induced replication. EMBO Rep. 17, 1731–1737 (2016).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  64. 64.

    Feretzaki, M. et al. RAD51-dependent recruitment of TERRA lncRNA to telomeres through R-loops. Nature 587, 303–308 (2020).

    ADS  PubMed  PubMed Central  Article  CAS  Google Scholar 

  65. 65.

    Sarek, G., Vannier, J. B., Panier, S., Petrini, J. H. J. & Boulton, S. J. TRF2 recruits RTEL1 to telomeres in S phase to promote T-loop unwinding. Mol. Cell 61, 788–789 (2016).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  66. 66.

    Ginno, P. A., Lott, P. L., Christensen, H. C., Korf, I. & Chedin, F. R-loop formation is a distinctive characteristic of unmethylated human CpG island promoters. Mol. Cell 45, 814–825 (2012).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  67. 67.

    Nergadze, S. G. et al. CpG-island promoters drive transcription of human telomeres. RNA 15, 2186–2194 (2009).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  68. 68.

    Ribeiro de Almeida, C. et al. RNA helicase DDX1 converts RNA G-quadruplex structures into R-loops to promote igh class switch recombination. Mol. Cell 70, 650–662 e658 (2018).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  69. 69.

    Yewdell, W. T. & Chaudhuri, J. A transcriptional serenAID: the role of noncoding RNAs in class switch recombination. Int. Immunol. 29, 183–196 (2017).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  70. 70.

    Awad, A. et al. Full length RTEL1 is required for the elongation of the single-stranded telomeric overhang by telomerase. Nucleic Acids Res. 48, 7239–7251 (2020).

    CAS  PubMed  PubMed Central  Google Scholar 

  71. 71.

    Alter, B. P., Giri, N., Savage, S. A. & Rosenberg, P. S. Cancer in the National Cancer Institute inherited bone marrow failure syndrome cohort after fifteen years of follow-up. Haematologica 103, 30–39 (2018).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  72. 72.

    Garzia, A. et al. The E3 ubiquitin ligase and RNA-binding protein ZNF598 orchestrates ribosome quality control of premature polyadenylated mRNAs. Nat. Commun. 8, 16056 (2017).

    ADS  CAS  PubMed  PubMed Central  Article  Google Scholar 

Download references

Acknowledgements

We thank Christopher Lima and John Zinder for valuable advice and technical assistance throughout this project. We thank Dinshaw Patel and Wei Xie for help with SEC-MALS, and the members of the MSKCC proteomics core for assistance with proteomics analysis. We are grateful to all the members of the Petrini laboratory, Tom Kelly, Kenneth J. Marians, and Titia de Lange for helpful discussions, and to Jun Hyun Kim for help with flow cytometry. We thank Laura Feeney and Tom Kelly for critical reading of the manuscript. This work was supported by GM56888 (J.H.J.P), U54 OD020355 (J.H.J.P), R35GM136278 (J.H.J.P), the MSK Cancer Center Core Grant P30 CA008748 (J.H.J.P), the DOD award W81XWH-16-1-0218 (F.G), and the intramural research program of the Division of Cancer Epidemiology and Genetics, National Cancer Institute (S.A.S).

Author information

Affiliations

Authors

Contributions

F.G., A.G., H.W., C.C., and M.H. performed experiments. F.G., A.G., H.W., M.H., and J.H.J.P analyzed data. S.A.S. evaluated patients and contributed the patient lymphoblastoid cell lines. F.G. and J.H.J.P. wrote the manuscript. J.H.J.P. and T.T. provided general supervision and mentorship.

Corresponding author

Correspondence to John H. J. Petrini.

Ethics declarations

Competing interests

J.H.J.P. is a consultant for Novus Biologicals and ATROPOS Therapeutics, which are not competing interests with this study. The remaining authors declare no competing interests.

Additional information

Peer review information Nature Communications thanks Kate Beishline and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Source data

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Ghisays, F., Garzia, A., Wang, H. et al. RTEL1 influences the abundance and localization of TERRA RNA. Nat Commun 12, 3016 (2021). https://doi.org/10.1038/s41467-021-23299-2

Download citation

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing